| scholarly article | Q13442814 |
| P50 | author | Vijayalakshmi Ravindranath | Q18211727 |
| P2093 | author name string | Faraz Ahmad | |
| David A Bennett | |||
| Debajyoti Das | |||
| Reddy Peera Kommaddi | |||
| Khader Valli Rupanagudi | |||
| Latha Diwakar | |||
| Ruturaj Gowaikar | |||
| P2860 | cites work | Structure and physiological function of calpains | Q24530607 |
| Brain-Derived Neurotrophic Factor: Three Ligands, Many Actions | Q26795382 | ||
| Lysosome and calcium dysregulation in Alzheimer's disease: partners in crime | Q27693256 | ||
| Presence of calpain II immunoreactivity in senile plaques in Alzheimer's disease | Q48669811 | ||
| Dysregulation of TrkB Receptors and BDNF Function by Amyloid-β Peptide is Mediated by Calpain | Q48769291 | ||
| A rapid method for preparing synaptosomes: comparison, with alternative procedures | Q49135145 | ||
| Hypoxia increases Aβ-induced tau phosphorylation by calpain and promotes behavioral consequences in AD transgenic mice. | Q50763421 | ||
| Brain-derived neurotrophic factor mediates neuroprotection against Aβ-induced toxicity through a mechanism independent on adenosine 2A receptor activation. | Q52149355 | ||
| Synaptopathies: synaptic dysfunction in neurological disorders - A review from students to students | Q28077671 | ||
| Calpain 1 and Calpastatin expression is developmentally regulated in rat brain | Q28584194 | ||
| Detecting outliers: Do not use standard deviation around the mean, use absolute deviation around the median | Q29029331 | ||
| Spatial localization of m-calpain to the plasma membrane by phosphoinositide biphosphate binding during epidermal growth factor receptor-mediated activation | Q30478059 | ||
| RNAi targeting micro-calpain increases neuron survival and preserves hippocampal function after global brain ischemia | Q33912914 | ||
| Calpain activation promotes BACE1 expression, amyloid precursor protein processing, and amyloid plaque formation in a transgenic mouse model of Alzheimer disease | Q34107259 | ||
| Truncation and activation of GSK-3β by calpain I: a molecular mechanism links to tau hyperphosphorylation in Alzheimer's disease | Q35035648 | ||
| Synaptic therapy in Alzheimer's disease: a CREB-centric approach | Q35064948 | ||
| Calpain-mediated tau cleavage: a mechanism leading to neurodegeneration shared by multiple tauopathies | Q35136746 | ||
| Calpain dysregulation in Alzheimer's disease | Q35361462 | ||
| Truncation and Activation of Dual Specificity Tyrosine Phosphorylation-regulated Kinase 1A by Calpain I: A MOLECULAR MECHANISM LINKED TO TAU PATHOLOGY IN ALZHEIMER DISEASE. | Q35721878 | ||
| Withania somnifera reverses Alzheimer's disease pathology by enhancing low-density lipoprotein receptor-related protein in liver | Q35807544 | ||
| Overview and findings from the religious orders study | Q36130996 | ||
| Hippocampal Injections of Oligomeric Amyloid β-peptide (1-42) Induce Selective Working Memory Deficits and Long-lasting Alterations of ERK Signaling Pathway | Q36449089 | ||
| Epidermal growth factor activates m-calpain (calpain II), at least in part, by extracellular signal-regulated kinase-mediated phosphorylation | Q36571781 | ||
| Calpain and synaptic function | Q36586276 | ||
| Involvement of calpain activation in neurodegenerative processes. | Q36588397 | ||
| Upregulation of calpain activity precedes tau phosphorylation and loss of synaptic proteins in Alzheimer's disease brain | Q36758446 | ||
| Distinct roles for μ-calpain and m-calpain in synaptic NMDAR-mediated neuroprotection and extrasynaptic NMDAR-mediated neurodegeneration. | Q37345165 | ||
| Brain-derived neurotrophic factor: a dynamic gatekeeper of neural plasticity | Q37661598 | ||
| Calcium-activated neutral protease (calpain) system: structure, function, and regulation | Q37767409 | ||
| Regulation of calpain-2 in neurons: implications for synaptic plasticity | Q37798196 | ||
| Role of APP and Aβ in synaptic physiology | Q37878495 | ||
| Structure-function relationships in calpains. | Q38049358 | ||
| Targeting calpain in synaptic plasticity | Q38079000 | ||
| C-terminal truncation of GSK-3β enhances its dephosphorylation by PP2A. | Q38713373 | ||
| Calpain-1 and Calpain-2: The Yin and Yang of Synaptic Plasticity and Neurodegeneration | Q38732547 | ||
| The Study of Postmortem Human Synaptosomes for Understanding Alzheimer's Disease and Other Neurological Disorders: A Review. | Q39451622 | ||
| Preparation of synaptic plasma membrane and postsynaptic density proteins using a discontinuous sucrose gradient | Q40043676 | ||
| Isoform specific function of calpain 2 in regulating membrane protrusion | Q40527089 | ||
| Calpain: new perspectives in molecular diversity and physiological-pathological involvement. | Q40694801 | ||
| Calpain Activation in Alzheimer's Model Mice Is an Artifact of APP and Presenilin Overexpression. | Q41138030 | ||
| Activity profile of calpains I and II in chronically infarcted rat myocardium--influence of the calpain inhibitor CAL 9961. | Q41981503 | ||
| Brain-derived neurotrophic factor and epidermal growth factor activate neuronal m-calpain via mitogen-activated protein kinase-dependent phosphorylation | Q42917910 | ||
| Evidence supporting the role of calpain in the α-processing of amyloid-β precursor protein. | Q44211388 | ||
| Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease. | Q45967931 | ||
| Astroglial activation of extracellular-regulated kinase in early stages of Alzheimer disease | Q46060698 | ||
| Increased cerebrospinal fluid calpain activity and microparticle levels in Alzheimer's disease | Q48557228 | ||
| Calpain-2 contributes to neuropathic pain following motor nerve injury via up-regulating interleukin-6 in DRG neurons | Q48589410 | ||
| Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and amyloid precursor proteins | Q48601563 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | Alzheimer's disease | Q11081 |
| P304 | page(s) | 13119 | |
| P577 | publication date | 2018-09-03 | |
| P1433 | published in | Scientific Reports | Q2261792 |
| P1476 | title | Isoform-specific hyperactivation of calpain-2 occurs presymptomatically at the synapse in Alzheimer's disease mice and correlates with memory deficits in human subjects | |
| P478 | volume | 8 |
| Q124094957 | Chemical Stimulation of Rodent and Human Cortical Synaptosomes: Implications in Neurodegeneration |
| Q93197943 | Deletion of the Capn1 Gene Results in Alterations in Signaling Pathways Related to Alzheimer's Disease, Protein Quality Control and Synaptic Plasticity in Mouse Brain |
Search more.